Emerging Biopharma

Accelerate asset success to improve patient outcomes

Every decision matters on your asset journey. Partner with IQVIA’s dedicated team to navigate commercial journeys fueled by innovation and strategic insights, therapeutic expertise, and best-in-class tailored solutions that minimize risks and maximize return on investments. 

Partner with commercialization experts who share your destination

Biopharmas initializing first launch

Right-sized commercial solutions

Our success is measured by your success. We help you maximize the impact of your investments while maintaining control of your assets, with infrastructure support, expertise, and resources. Together, we can help you scale quickly, bringing your innovation to the patients who need it.

  • Optimize go to market strategies
  • Accelerate investor valuation
  • Build an efficient and effective operating model
Biopharmas navigating an evolving portfolio

Scale to accelerate growth

Get access to the resources, thought leadership and expertise to deliver the most value at launch and beyond as your portfolio grows. Stay one step ahead with the largest curated data sets, healthcare-grade AI, and therapeutic expertise to deliver short-term ROI and long-term prosperity.

  • Innovative analytics and insights
  • Optimize go to market strategies to commercialize with confidence
  • Future vision for life cycle management
Start small, dream big, succeed now

Develop and execute a winning asset launch strategy

For emerging biopharma and biotech companies to excel in today’s challenging environment, it’s critical to leverage a deep understanding of the patient profile and market dynamics throughout the journey from clinical to commercial. IQVIA Asset Maximizer is a comprehensive suite of solutions, delivered by experts dedicated to you, to help your breakthroughs get to patients, faster.

Asset success starts early for pharmaceutical companies with a need to ensure clinical trial design considers endpoints that demonstrate value to regulators, payers, prescribers, and the patient. Communicating that value requires an adaptable, omnichannel approach to activate and engage all stakeholders at launch and throughout the product lifecycle. Work with IQVIA, the global leader in clinical development, Real World Evidence, and the commercialization of new treatments to deliver a winning asset at launch and beyond.

IQVIA BIOTECH

Clinical development solutions built for biotech success

Hit your clinical development milestones and maximize your patient impact.

EMERGING BIOPHARMA ANALYTICS

Data driven insights that maximize commercial success

For emerging biotech companies, launching clinical innovations requires vision, resources, and customized data. From crafting analytical approaches to understanding specialty markets, our team of experts can help you build more impactful commercialization action plans.

Connecting people, intelligence, and innovation

IQVIA creates the connections for clinical and commercial customers to bring therapies to market and to the patients who need them. 

Contact Us